Julie K. Heimbach

31.8k total citations · 12 hit papers
230 papers, 19.0k citations indexed

About

Julie K. Heimbach is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Julie K. Heimbach has authored 230 papers receiving a total of 19.0k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Surgery, 130 papers in Hepatology and 68 papers in Epidemiology. Recurrent topics in Julie K. Heimbach's work include Organ Transplantation Techniques and Outcomes (97 papers), Liver Disease and Transplantation (95 papers) and Liver Disease Diagnosis and Treatment (64 papers). Julie K. Heimbach is often cited by papers focused on Organ Transplantation Techniques and Outcomes (97 papers), Liver Disease and Transplantation (95 papers) and Liver Disease Diagnosis and Treatment (64 papers). Julie K. Heimbach collaborates with scholars based in United States, Canada and Netherlands. Julie K. Heimbach's co-authors include Laura Kulik, Jorge A. Marrero, Lewis R. Roberts, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michaël Abécassis, Charles B. Rosen, Michael Charlton and Gregory J. Gores and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Julie K. Heimbach

216 papers receiving 18.8k citations

Hit Papers

Diagnosis, Staging, and Management of Hepat... 2010 2026 2015 2020 2018 2017 2011 2023 2010 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
    2018 3.1k citations Julie K. Heimbach et al. Hepatology profile →
  2. AASLD guidelines for the treatment of hepatocellular carcinoma
    2017 2.9k citations Julie K. Heimbach et al. Hepatology profile →
  3. Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
    2011 843 citations Kymberly D. Watt, Julie K. Heimbach et al. Gastroenterology profile →
  4. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
    2023 740 citations Neil Mehta, Julie K. Heimbach et al. Hepatology profile →
  5. Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study
    2010 564 citations Julie K. Heimbach et al. American Journal of Transplantation profile →
  6. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
    2019 516 citations Julie K. Heimbach et al. profile →
  7. Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
    2012 351 citations Denise M. Harnois, James R. Burton et al. Gastroenterology profile →
  8. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis
    2017 336 citations Julie K. Heimbach et al. Hepatology profile →
  9. New advances in the diagnosis and management of hepatocellular carcinoma
    2020 290 citations Julie K. Heimbach et al. profile →
  10. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
    2021 288 citations Julie K. Heimbach, Patrick S. Kamath et al. Gastroenterology profile →
  11. Hilar Cholangiocarcinoma: expert consensus statement
    2015 268 citations Julie K. Heimbach et al. profile →
  12. Liver Transplantation 2023: Status Report, Current and Future Challenges
    2023 127 citations Norah A. Terrault, Marina Berenguer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie K. Heimbach United States 59 12.4k 8.5k 8.3k 3.4k 2.9k 230 19.0k
Myron Schwartz United States 77 12.9k 1.0× 7.4k 0.9× 6.9k 0.8× 3.0k 0.9× 3.9k 1.3× 328 20.9k
P. Neuhaus Germany 59 8.4k 0.7× 9.3k 1.1× 6.1k 0.7× 3.2k 0.9× 5.0k 1.7× 596 18.0k
Daniel Azoulay France 72 13.5k 1.1× 10.0k 1.2× 4.9k 0.6× 3.9k 1.1× 8.2k 2.8× 443 20.4k
René Adam France 76 15.6k 1.3× 10.7k 1.3× 4.7k 0.6× 3.7k 1.1× 9.7k 3.4× 415 21.4k
Laura Kulik United States 61 15.9k 1.3× 5.7k 0.7× 8.4k 1.0× 3.6k 1.1× 2.8k 1.0× 149 20.1k
Yasuhiko Sugawara Japan 58 10.2k 0.8× 8.1k 1.0× 4.5k 0.5× 2.1k 0.6× 2.4k 0.8× 502 14.2k
Denis Castaing France 69 13.9k 1.1× 9.5k 1.1× 5.0k 0.6× 3.1k 0.9× 6.9k 2.4× 210 17.8k
Antonio Daniele Pinna Italy 60 7.9k 0.6× 6.7k 0.8× 4.7k 0.6× 1.6k 0.5× 1.9k 0.7× 403 12.6k
Norihiro Kokudo Japan 80 16.4k 1.3× 12.5k 1.5× 7.2k 0.9× 5.8k 1.7× 7.3k 2.5× 727 26.0k
Alessandro Cucchetti Italy 54 7.2k 0.6× 4.5k 0.5× 4.2k 0.5× 1.7k 0.5× 2.1k 0.7× 262 10.2k

Countries citing papers authored by Julie K. Heimbach

Since Specialization
Citations

This map shows the geographic impact of Julie K. Heimbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie K. Heimbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie K. Heimbach more than expected).

Fields of papers citing papers by Julie K. Heimbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie K. Heimbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie K. Heimbach. The network helps show where Julie K. Heimbach may publish in the future.

Co-authorship network of co-authors of Julie K. Heimbach

This figure shows the co-authorship network connecting the top 25 collaborators of Julie K. Heimbach. A scholar is included among the top collaborators of Julie K. Heimbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie K. Heimbach. Julie K. Heimbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DuBrock, Hilary M., Laurent Savale, Olivier Sitbon, et al.. (2025). International Liver Transplantation Society practice guideline update on portopulmonary hypertension. Liver Transplantation. 32(2). 296–314. 2 indexed citations
2.
Ahn, Joseph, Puru Rattan, Patrick Starlinger, et al.. (2025). AI-Cirrhosis-ECG (ACE) score for predicting decompensation and liver outcomes. JHEP Reports. 7(5). 101356–101356. 1 indexed citations
3.
Mehta, Neil, Scott W. Biggins, Sumeet K. Asrani, et al.. (2024). Model of Urgency for Liver Transplantation in Hepatocellular Carcinoma: A Practical Model to Prioritize Patients With Hepatocellular Carcinoma on the Liver Transplant Waitlist. Gastroenterology. 168(4). 784–794.e4. 1 indexed citations
4.
Samuel, Didier, Eléonora De Martin, Thomas Berg, et al.. (2024). EASL Clinical Practice Guidelines on liver transplantation. Journal of Hepatology. 81(6). 1040–1086. 34 indexed citations
5.
Lee, Charles, Amit K. Mathur, Shennen A. Mao, et al.. (2024). Prolonged time from cross-clamp until normothermic machine perfusion start is associated with an increased risk of early allograft dysfunction following DCD liver transplant. Liver Transplantation. 31(5). 616–622. 2 indexed citations
6.
Grotz, Travis E., Charles B. Rosen, Julie K. Heimbach, et al.. (2024). Management and Long‐Term Outcomes of Patients With Hepatic Epithelioid Hemangioendothelioma. Journal of Surgical Oncology. 130(5). 1062–1069.
7.
Kaplan, Alyson, Elizabeth S. Aby, Christopher J. Sonnenday, et al.. (2024). Financial toxicity in living donor liver transplantation: A call to action for financial neutrality. American Journal of Transplantation. 24(10). 1742–1754. 2 indexed citations
8.
Vail, Emily A., Rita N. Bakhru, Todd Sarge, et al.. (2024). Best Practices for Intensivists Planning and Opening Hospital-Based Deceased Organ Donor Care Units. SHILAP Revista de lepidopterología. 3(1). 100110–100110. 2 indexed citations
9.
Cheung, Angela, Brian D. Juran, Erik M. Schlicht, et al.. (2022). DNA Methylation Profile of Liver Tissue in End-Stage Cholestatic Liver Disease. Epigenomics. 14(8). 481–497. 5 indexed citations
10.
Sussman, Jon, Daniel S. Ubl, Kristopher P. Croome, et al.. (2021). Variation in opioid prescribing patterns after abdominal transplant surgery. Clinical Transplantation. 35(10). e14439–e14439. 6 indexed citations
11.
Jalan‐Sakrikar, Nidhi, Thiago M. de Assuncao, Feda H. Hamdan, et al.. (2021). Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation. Hepatology Communications. 6(2). 345–360. 18 indexed citations
12.
Croome, Kristopher P., Amit K. Mathur, Shennen A. Mao, et al.. (2020). Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis. American Journal of Transplantation. 20(9). 2449–2456. 34 indexed citations
13.
Rosen, Charles B., et al.. (2020). Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation. Cancers. 12(11). 3157–3157. 20 indexed citations
14.
Eaton, John E., Christopher L. Welle, Shannon P. Sheedy, et al.. (2020). Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis. Hepatology. 73(5). 1868–1881. 25 indexed citations
15.
Burton, James R., Norah A. Terrault, David S. Goldberg, et al.. (2019). Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation. Transplantation. 104(3). 476–481. 19 indexed citations
16.
Brondfield, Max N., Jennifer L. Dodge, Ryutaro Hirose, et al.. (2019). Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short‐Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change. Liver Transplantation. 26(5). 662–672. 11 indexed citations
17.
Heimbach, Julie K., Tsung‐Teh Wu, Sarah M. Jenkins, et al.. (2016). Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants. The American Journal of Surgical Pathology. 40(4). 510–518. 30 indexed citations
18.
Duarte‐Rojo, Andrés, Amber Thompson, Julie K. Heimbach, et al.. (2013). 505 DONOR IL28B TT-POLYMORPHISM IS ASSOCIATED WITH INCREASED INCIDENCE OF HEPATIC STEATOSIS IN LIVER TRANSPLANT PATIENTS WITH CHRONIC HEPATITIS C. Journal of Hepatology. 58. S207–S208. 1 indexed citations
19.
Rosen, Charles B., Julie K. Heimbach, & Gregory J. Gores. (2007). Current status of liver transplantation for hilar cholangiocarcinoma. Current Opinion in Organ Transplantation. 12(3). 215–219. 1 indexed citations
20.
Rea, David, Julie K. Heimbach, Joseph P. Grande, et al.. (2006). Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney International. 70(9). 1636–1641. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myron Schwartz Breakdown of academic impact, for papers by P. Neuhaus Breakdown of academic impact, for papers by Daniel Azoulay Breakdown of academic impact, for papers by René Adam Breakdown of academic impact, for papers by Laura Kulik Breakdown of academic impact, for papers by Yasuhiko Sugawara Breakdown of academic impact, for papers by Denis Castaing Breakdown of academic impact, for papers by Antonio Daniele Pinna Breakdown of academic impact, for papers by Norihiro Kokudo Breakdown of academic impact, for papers by Alessandro Cucchetti
Rankless by CCL
2026